7 research outputs found
Mosaic loss of the Y chromosome in human neurodegenerative and oncological diseases
The development of new biomarkers for prediction and early detection of human diseases, as well as for monitoring the response to therapy is one of the most relevant areas of modern human genetics and genomics. Until recently, it was believed that the function of human Y chromosome genes was limited to determining sex and controlling spermatogenesis. Thanks to occurance of large databases of the genome-wide association study (GWAS), there has been a transition to the use of large samples for analyzing genetic changes in both normal and pathological conditions. This has made it possible to assess the association of mosaic aneuploidy of the Y chromosome in somatic cells with a shorter lifespan in men compared to women. Based on data from the UK Biobank, an association was found between mosaic loss of the Y chromosome (mLOY) in peripheral blood leukocytes and the age of men over 70, as well as a number of oncological, cardiac, metabolic, neurodegenerative, and psychiatric diseases. As a result, mLOY in peripheral blood cells has been considered a potential marker of biological age in men and as a marker of certain age-related diseases. Currently, numerous associations have been identified between mLOY and genes based on GWAS and transcriptomes in affected tissues. However, the exact cause of mLOY and the impact and consequences of this phenomenon at the whole organism level have not been established. In particular, it is unclear whether aneuploidy of the Y chromosome in blood cells may affect the development of pathologies that manifest in other organs, such as the brain in Alzheimer’s disease, or whether it is a neutral biomarker of general genomic instability. This review examines the main pathologies and genetic factors associated with mLOY, as well as the hypotheses regarding their interplay. Special attention is given to recent studies on mLOY in brain cells in Alzheimer’s disease
Whole exome sequencing links dental tumor to an autosomal-dominant mutation in ANO5 gene associated with gnathodiaphyseal dysplasia and muscle dystrophies
Tumors of the jaws may represent different human disorders and frequently associate with pathologic bone fractures. In this report, we analyzed two affected siblings from a family of Russian origin, with a history of dental tumors of the jaws, in correspondence to original clinical diagnosis of cementoma consistent with gigantiform cementoma (GC, OMIM: 137575). Whole exome sequencing revealed the heterozygous missense mutation c.1067G \u3e A (p.Cys356Tyr) in ANO5 gene in these patients. To date, autosomal-dominant mutations have been described in the ANO5 gene for gnathodiaphyseal dysplasia (GDD, OMIM: 166260), and multiple recessive mutations have been described in the gene for muscle dystrophies (OMIM: 613319, 611307); the same amino acid (Cys) at the position 356 is mutated in GDD. These genetic data and similar clinical phenotypes demonstrate that the GC and GDD likely represent the same type of bone pathology. Our data illustrate the significance of mutations in single amino-acid position for particular bone tissue pathology. Modifying role of genetic variations in another gene on the severity of the monogenic trait pathology is also suggested. Finally, we propose the model explaining the tissue-specific manifestation of clinically distant bone and muscle diseases linked to mutations in one gene
Recommended from our members
In silico Search for the Expressed Sequences in the Region q14.3 of Human Chromosome 13
Recommended from our members
Modern strategy of tumor suppressor gene cloning: B-cell chronic lymphocytic leukemia candidate genes search as an illustration
Genes that normally function to prevent or suppress malignancy are known as "tumor suppressor genes" or TSG. It is supposed that the chromosomal region lost in the tumor cells harbors TSG preventing cancer. The examination of this region in the normal chromosome would permit identification of the particular suppressor gene. The methods employed in such search are diverse. As a rule, success is achieved by combining cytogenetic, genetic and physical genome mapping with analysis of genomic and cDNA clones. We have constructed a cosmid contig in the 13q14.3 region which is expected to contain a putative B-cell chronic lymphocytic leukemia (BCLL) TSG, cDNA clones corresponding to new human gene Leu5 have been found to locate nearby the borders of homo- and hemizygous deletions in BCLL patients. Gene Leu5 encodes a zinc-finger protein that shares homology with some mammalian genes taking part in early embryogenesis and tumor progression. Leu5 gene could be an interesting candicate for BCLL TSG